来曲唑
不育
芳香化酶抑制剂
促排卵
医学
雌激素
临床试验
排卵
妇科
芳香化酶
多囊卵巢
生物信息学
男性不育
内科学
不明原因不孕症
肿瘤科
生物
怀孕
激素
乳腺癌
癌症
遗传学
作者
Aimin Yang,Na Cui,Yifei Sun,Guimin Hao
标识
DOI:10.3389/fendo.2021.676133
摘要
Letrozole, an aromatase inhibitor that blocks estrogen synthesis by inhibiting the final step of the estrogen biosynthetic pathway, has been used in the applications of a wide range of infertility settings. It has been more than 20 years since the initial clinical trial of letrozole for ovulation induction. In light of the accumulating clinical and basic evidence, the efficacy and safety of letrozole have been identified. This mini review focuses on our current knowledge of the applications and mechanisms of letrozole for female infertility and various questions are put forward about how letrozole could be more effectively used.
科研通智能强力驱动
Strongly Powered by AbleSci AI